Subscribe Now
Rankings
Magazine
Newsletters
Podcasts
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
Rankings
See All Rankings
Fortune 500
Global 500
40 Under 40
GREAT PLACE TO WORK LISTS
Best MBA Programs
Magazine
April/May 2023
February/March 2023
December 2022/January 2023
October/November 2022
Newsletters
Podcasts
More
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
SEARCH
SEARCH
SIGN IN
Subscribe Now
Bayer
Newsletters
Shareholders are forcing Bayer’s CEO out. What do they expect from his replacement?
BY
Eamon Barrett
Finance
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
BY
Paige McGlauflin
Health
CureVac scraps its first-generation COVID-19 vaccine candidate, shares tumble
BY
David Meyer
Health
These four COVID-19 vaccines could soon join the pandemic fight
BY
David Meyer
Health
As alarm grows over Europe’s dwindling vaccine supplies, Bayer could offer its factories to the cause
BY
David Meyer
Health
Bayer strikes deal to aid CureVac in its COVID-19 vaccine rollout
BY
David Meyer
Newsletters
The dollar, Bitcoin soar as the markets contend with a dreaded, contested election
BY
Bernhard Warner
International
Bayer could settle the Roundup cancer litigation, but the drama is far from over
BY
David Meyer
International
Bayer agrees to pay $12 billion in legal settlements, in effort to put Roundup scandal behind it
BY
Jef Feeley
,
Tim Loh
, and others
Finance
From beekeepers to giant pension funds, activist shareholders are being silenced by the coronavirus
BY
Bernhard Warner
and
Katherine Dunn
International
Bayer reaches verbal deal to settle up to 85,000 Roundup cancer lawsuits
BY
Jef Feeley
,
Tim Loh
, and others
Newsletters
Big pharma’s big chance
BY
Alan Murray
and
Katherine Dunn
International
Bayer says Roundup legal fiasco may force it to sell assets or borrow on bad terms
BY
Tim Loh
and
Bloomberg
Health
Bayer may pay $10 billion to settle Roundup cancer cases from its Monsanto deal
BY
Jef Feeley
,
Tim Loh
, and others
Finance
As Roundup Lawsuits Pile Up by the Thousands, Bayer Remains Defiant
BY
Adrian Croft
Load More
Most Popular
Lifestyle
America’s national beer could soon be Mexican as Memorial Day weekend sales drop plunges Bud Light further into crisis
BY
Christiaan Hetzner
Commentary
The return-to-office wars could end in a stalemate as we all reach the same conclusion about what the flexible future...
BY
Terri R. Kurtzberg
and
Mason Ameri
Personal Finance
Getting rich is ‘surprisingly simple’ if you follow a 3-step strategy, says an expert on self-made wealth
BY
Jane Thier